Solana Company
HSDT
NASDAQ·Financial Services·Asset Management·Mkt cap $130.8M
$2.24
▼ -4.68%
P/E
—
Mkt Cap
$130.8M
52-Wk Range
$1.19–$25.50
52-Week Range
$1.19 - $25.50
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 61.9% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary tongue-based neurostimulation technology with clinical validation
- Non-invasive platform approach reducing patient risk and adoption barriers
- Strong intellectual property portfolio and patent protection
- Established partnerships and licensing agreements in neurological care
Bear Case
1 risk
- Average volatility.
Growth
Mild headwinds expected
Expanding clinical indications and regulatory approvals for neuromodulation devices
Value
Deep value opportunity - significant discount to Medical Devices peers
Momentum
Hot
+62.3% over 3m
Quality
Excellent
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying HSDT right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 5, 2026
AUG 14, 2026
Reported EPS of -$0.38 vs -$0.02 consensus (-1800.0% surprise). Revenue of $2.5M vs $3.5M expected (-27.8%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-1800.0%
Revenue trend · last 8Q
—
—
-64%
-76%
+1267%
+3339%
+7290%
+5774%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$51.0K
$152.0K
$49.0K
$43.0K
$697.0K
$5.2M
$3.6M
$2.5M
Margins · last 8Q
Gross
97.0%
Operating
—
Profit
-1197.8%
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: B. Riley · Sep 3, 2026
vs Industry
How HSDT stacks vs Asset Management
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related